Federal Register / Vol. 72, No. 165 / Monday, August 27, 2007 / Notices 49017 

SAFEGUARDS: 

In accordance with the requirements 

of 42 CFR 2.16, USMS EAP, contractor 

records are stored in a secure 

environment. Access to USMS EAP 

records is restricted to designated USMS 

EAP personnel, except as otherwise 

permitted by law or with the written 

consent of the individual. Vouchers 

prepared to effect payment for services 

rendered by the contractors in 

performance of the contract do not 

contain individual identifiers. Invoices 

prepared by contractors located outside 

the Washington, DC metropolitan area 

are sent by first-class mail to the 

designated member(s) of the local 

contractors contracted with the USMS. 

In turn, invoices or other records 

prepared in support of payment 

vouchers which contain individual 

identifiers are hand-carried by the local 

contractors to the EAP Administrator 

who retains the supporting 

documentation. Records are maintained 

in locked metal safes. Entry to 

headquarters is restricted by 24-hour 

guard service to employees with official 

and electronic identification. 

Access to contractors records is 

restricted to a designated member(s) of 

the contractors, except as otherwise 

provided by law or with the written 

consent of the individual. Contractors 

records are stored in locked files also. 

RETENTION AND DISPOSAL: 

Records, paper or electronic, are 

retained for three years after the 

individual ceases contact with the 

USMS EAP and/or the contractor unless 

a longer retention period is necessary 

because of pending administrative or 

judicial proceedings. In such cases, the 

records are retained for six months after 

the case is closed. At that time the 

records are destroyed by shredding 

(General Records Schedules 26 and 36). 

SYSTEM MANAGER(S) AND ADDRESS: 

Employee Assistance Program 

Administrator, Health and Safety Team, 

Human Resources Division, United 

States Marshals Service, CS–3, 

Washington, DC 20530–1000. 

NOTIFICATION PROCEDURE: 

Same as ‘‘Record access procedures.’’

RECORD ACCESS PROCEDURES: 

Address all requests for access to the 

USMS EAP records in writing to system 

manger identified above. Address all 

requests for records maintained by the 

contractor to these service providers. 

Address(es) of these service providers 

may be obtained by contacting the 

USMS EAP Office. Clearly mark the 

envelope and letter ‘‘Privacy Act 

Request.’’ Clearly indicate the name of 

the requester, nature of the record 

sought, and approximate date of the 

record. In addition, provide the required 

verification of identity (28 CFR 16.41(d)) 

and a return address for transmitting the 

information. 

CONTESTING RECORD PROCEDURES: 

Direct all requests to contest or amend 

information in accordance with the 

procedures outlined under ‘‘Record 

access procedures.’’ State clearly and 

concisely the information being 

contested, the reasons for contesting it, 

and the proposed amendment to the 

information sought. Clearly mark the 

letter and envelope ‘‘Privacy Act 

Amendment Request.’’

RECORD SOURCE CATEGORIES: 

Records are generated by the EAP 

client who is the subject of the record; 

USMS EAP personnel; the contractors, 

and the specialized service providers; 

the USMS Human Resources Division; 

and the employee’s supervisor. In the 

case of a confirmed, unjustified positive 

drug test, records may also be generated 

by the staff of the Drug-Free Workplace 

Program and the Medical Review 

Officer. 

EXEMPTIONS CLAIMED FOR THE SYSTEM: 

None. 

[FR Doc. E7–16894 Filed 8–24–07; 8:45 am] 

BILLING CODE 4410–04–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—the Nanoparticle Flow 

Processing Consortium 

Notice is hereby given that, on July 

16, 2007, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Nanoparticle Flow 

Processing Consortium has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing (1) the identities 

of the parties to the venture and (2) the 

nature and objectives of the venture. 

The notifications were filed for the 

purpose of invoking the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. 

Pursuant to Section 6(b) of the Act, 

the identities of the parties to the 

venture are: 3M Company, St. Paul, MN; 

The Proctor & Gamble Company, 

Cincinnati, OH; Corning Incorporated, 

Corning, NY; BASF Aktiengesellschaft, 

Ludwigshafen, Germany, and Imperial 

Chemical Industries PLC, London, 

United Kingdom. The general area of 

Nanoparticle Flow Processing 

Consortium’s planned activity is to: (1) 

Develop, test, and validate computersimulation technologies of near-term 

application that can improve the quality 

and reduce the cost of nanoparticle 

suspension/dispersion manufacture 

(including suspension stability and 

processibility); (2) transfer the 

technology developed under the 

Research and Development Program in 

a manner that offers the Consortium 

members opportunities for commercial 

advantage; and (3) develop 

methodologies and aptitude for 

modeling and simulation of multiscale 

phenomena intrinsic to the stability and 

dynamics of dense, nanoparticle 

suspensions. This development will be 

synergistic and applicable to many U.S. 

Department of Energy campaigns for 

simulation (viz. C6, ASC, and other 

science and technology initiatives like 

those underpinning MESA). 

J. Robert Kramer II, 

Director of Operations, Antitrust Division. 

[FR Doc. 07–4166 Filed 8–24–07; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—National Center for 

Manufacturing Sciences, Inc. 

Notice is hereby given that, on July 

24, 2007, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), National Center for 

Manufacturing Sciences, Inc. (‘‘NCMS’’) 

has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Ahura Scientific, Inc., 

Wilmington, MA; Ben Franklin 

Technology Partners, Philadelphia, PA; 

Camber Corporation, Huntsville, AL; 

City of Detroit Information Technology 

Services Dept., Detroit, MI; ElectroMechanical Associates, Inc., Ann Arbor, 

MI; H.A. Burrow Pattern Works, Inc., La 

Habra, CA; I.D. Systems, Inc., 

Hackensack, NJ; MichBio, Ann Arbor, 

MI; Oxonica plc, Mountain View, CA; 

Purdue University, West Lafayette, IN; 


rmajette on PROD1PC64 with NOTICES
49018 Federal Register / Vol. 72, No. 165 / Monday, August 27, 2007 / Notices 

Radian Tool & Engineering, Troy, MI; 

and Savant Technology Group, Inc., 

Ann Arbor, MI have been added as 

parties to this venture. Also, Anautics, 

Inc., Oklahoma City, OK; Campfire 

Interactive, Inc., Ann Arbor, MI; 

Cleveland Advanced Manufacturing 

Program (CAMP), Cleveland, OH; CorMet Inc., Brighton, MI; Fraunhofer USA, 

Plymouth, MI; Integrated Technologies, 

Inc., Danville, VT; Leszynski Group Inc., 

Bellevue, WA; Midwest Thermal Spray, 

Farmington Hills, MI; and Raytheon 

Systems Company, McKinney, TX have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and NCMS 

intends to file additional written 

notification disclosing all changes in 

membership. 

On February 20, 1987, NCMS filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on March 17, 1987 (52 FR 8375). 

The last notification was filed with 

the Department of Justice on February 

15, 2007. A notice was published in the 

Federal Register pursuant to Section 

6(b) of the Act on March 15, 2007 (72 

FR 12198). 

J. Robert Kramer II, 

Director of Operations, Antitrust Division. 

[FR Doc. 07–4165 Filed 8–24–07; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated April 17, 2007, and 

published in the Federal Register on 

April 30, 2007, (72 FR 21298), Amri 

Rensselaer, Inc. (formerly: Organichem 

Corporation), 33 Riverside Avenue, 

Rensselaer, New York 12144, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Oxymorphone (9652), a basic class of 

controlled substance listed in schedule 

II. 

The company plans on manufacturing 

the listed controlled substance in bulk 

for sale to its customer. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of Amri 

Rensselaer, Inc. to manufacture the 

listed basic class of controlled substance 

is consistent with the public interest at 

this time. DEA has investigated Amri 

Rensselaer, Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic class of controlled substance 

listed. 

Dated: August 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–16856 Filed 8–24–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on June 5, 2007, 

Boehringer Ingelheim Chemicals Inc., 

2820 N. Normandy Drive, Petersburg, 

Virginia 23805, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedule I and II: 

Drug Schedule 

Tetrahydrocannabinols (7370) ..... I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Methadone (9250) ........................ II 

Methadone Intermediate (9254) ... II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers for formulation 

into finished pharmaceuticals. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), Washington, DC 20537, or any 

being sent via express mail should be 

sent to Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 2401 Jefferson Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than October 26, 2007. 

Dated: August 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administraton, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–16855 Filed 8–24–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations (CFR), 

1301.34(a), this is notice that on June 5, 

2007, Boehringer Ingelheim Chemicals, 

Inc., 2820 N. Normandy Drive, 

Petersburg, Virginia 23805, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Phenylacetone (8501), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance to bulk 

manufacture amphetamine. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

being sent via regular mail should be 

addressed, in quintuplicate, to the Drug 

Enforcement Administration, Office of 

Diversion Control, Federal Register 

Representative (ODL), Washington, DC 


rmajette on PROD1PC64 with NOTICES